QS Investors’s Cantel Medical Corporation CMD Stock Holding History

QS Investors’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-700	Closed	-$26K	–	1729
2020 Q1	$26K	Hold	700	–	–	﹤0.01%	1465
2019 Q4	$49K	Hold	700	–	–	﹤0.01%	1463
2019 Q3	$53K	Hold	700	–	–	﹤0.01%	1473
2019 Q2	$57K	Hold	700	–	–	﹤0.01%	1481
2019 Q1	$47K	Sell	700 -5	-0.7%	-$379	﹤0.01%	1506
2018 Q4	$53K	Hold	705	–	–	﹤0.01%	1447
2018 Q3	$65K	Hold	705	–	–	﹤0.01%	1462
2018 Q2	$69K	Hold	705	–	–	﹤0.01%	1477
2018 Q1	$79K	Hold	705	–	–	﹤0.01%	1417
2017 Q4	$73K	Hold	705	–	–	﹤0.01%	1419
2017 Q3	$66K	Hold	705	–	–	﹤0.01%	1469
2017 Q2	$55K	Hold	705	–	–	﹤0.01%	1494
2017 Q1	$56K	Buy	705 +700	+14,000%	+$55.6K	﹤0.01%	1487
2016 Q4	$1K	Hold	5	–	–	﹤0.01%	1841
2016 Q3	$1K	Hold	5	–	–	﹤0.01%	1838
2016 Q2	$1K	Hold	5	–	–	﹤0.01%	1893
2016 Q1	$1K	Hold	5	–	–	﹤0.01%	1868
2015 Q4	$1K	Buy	+5	New	+$305	﹤0.01%	1929

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

QS Investors's CMD Position: Q2 2020 in Review

QS Investors sold out of Cantel Medical Corporation (CMD) in Q2 2020, closing a stake of 700 shares — an estimated $26K sold.

QS Investors first reported a position in CMD in Q4 2015 and held it in 18 quarters. The position peaked at $79K in Q1 2018. 210 funds tracked by Wall St. Rank hold CMD as of Q2 2020.

QS Investors reported no remaining Cantel Medical Corporation position as of Q2 2020 after selling out during the quarter.
QS Investors sold 700 Cantel Medical Corporation shares in Q2 2020, an estimated $26K.
QS Investors first reported a position in Cantel Medical Corporation in Q4 2015 and held it in 18 quarters.
QS Investors's Cantel Medical Corporation position peaked at $79K in Q1 2018.
210 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2020.

Based on QS Investors's 13F filing for Q2 2020, filed 14 Aug 2020.